<DOC>
	<DOCNO>NCT01725880</DOCNO>
	<brief_summary>The purpose study determine long term safety preliminary efficacy intramedullary transplantation HuCNS-SC cell subject thoracic spinal cord trauma .</brief_summary>
	<brief_title>Long-Term Follow-Up Transplanted Human Central Nervous System Stem Cells ( HuCNS-SC ) Spinal Cord Trauma Subjects</brief_title>
	<detailed_description>The investigation multi-year observational study follow completion open-label , single dose Phase I/II study involve transplantation allogeneic HuCNS-SC cell 12 subject thoracic spinal cord injury . Subjects monitor routine interval safety preliminary efficacy four year . The LTFU study commence follow one year post-transplantation termination visit Phase I/II investigation .</detailed_description>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Must undergone HuCNSSC transplantation subject Phase I/II trial Must agree comply good faith condition study attend require study visit Subjects receive receive offprotocol immunosuppressive medication Subjects , completion Phase I/II trial ( Protocol # CLN02SC ) , enter enter investigational study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Spinal Cord Injury</keyword>
	<keyword>HuCNS-SC cell</keyword>
	<keyword>Human Neural Stem Cells</keyword>
	<keyword>Neural Stem Cells</keyword>
	<keyword>Stem Cells</keyword>
</DOC>